Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-20

FDA Approved: DEFERASIROX — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved Deferasirox as the generic version under an Original Application (ANDA) submitted by Bionpharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)